The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination
- PMID: 16564115
- DOI: 10.1016/j.vaccine.2006.02.017
The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination
Abstract
We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands. Data on seroprevalence of varicella zoster virus in the general population (1995-1996), consultations of general practitioners for varicella (2000-2002) and herpes zoster (1998-2001) and hospital admissions due to varicella (1994-2001) and herpes zoster (1994-2001) in The Netherlands were analysed. The seropositivity increased sharply with age from 18.4% for both 0- and 1-year-olds, to 48.9%, 59.0%, 75.7% and 93.0% for 2-, 3-, 4- and 5-year-olds, respectively, and varied between 97.5% and 100% for older age groups. The average annual incidence of GP-consultations amounted to 253.5 and 325.0 per 100,000 for varicella and herpes zoster, respectively. The incidence of hospital admission due to varicella and herpes zoster was 1.3 (2.3 including side diagnosis) and 2.7 (5.8) per 100,000, respectively. Whilst for varicella, the incidence of GP-consultations and hospital admissions were highest in childhood, for herpes zoster, these were highest in elderly. Insight into epidemiology of varicella zoster is needed for the assessment of the desirability of introduction of routine varicella zoster vaccination.
Similar articles
-
[Modelling the impact of vaccination on the epidemiology of varicella zoster virus].Rev Epidemiol Sante Publique. 2008 Oct;56(5):323-31. doi: 10.1016/j.respe.2008.07.087. Epub 2008 Oct 31. Rev Epidemiol Sante Publique. 2008. PMID: 18951741 French.
-
Modelling the impact of varicella vaccination on varicella and zoster.Epidemiol Infect. 2010 Apr;138(4):469-81. doi: 10.1017/S0950268809990768. Epub 2009 Oct 2. Epidemiol Infect. 2010. PMID: 19796447
-
Epidemiology of Varicella-Zoster Virus in England and Wales.J Med Virol. 2003;70 Suppl 1:S9-14. doi: 10.1002/jmv.10313. J Med Virol. 2003. PMID: 12627480
-
The effect of vaccination on the epidemiology of varicella zoster virus.J Infect. 2002 May;44(4):211-9. doi: 10.1053/jinf.2002.0988. J Infect. 2002. PMID: 12099726 Review.
-
The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.J Infect Dis. 2008 Mar 1;197 Suppl 2:S224-7. doi: 10.1086/522162. J Infect Dis. 2008. PMID: 18419401 Review.
Cited by
-
Increased seroprevalence of IgG-class antibodies against cytomegalovirus, parvovirus B19, and varicella-zoster virus in women working in child day care.BMC Public Health. 2012 Jun 22;12:475. doi: 10.1186/1471-2458-12-475. BMC Public Health. 2012. PMID: 22726391 Free PMC article.
-
An ICU patient with spots and a peculiar pneumonia.BMJ Case Rep. 2013 Mar 20;2013:bcr2013008693. doi: 10.1136/bcr-2013-008693. BMJ Case Rep. 2013. PMID: 23519509 Free PMC article.
-
Herpes zoster-associated mortality in Europe: a systematic review.BMC Public Health. 2015 May 5;15:466. doi: 10.1186/s12889-015-1753-y. BMC Public Health. 2015. PMID: 25940080 Free PMC article. Review.
-
Epidemiology of herpes zoster infection among patients treated in primary care centres in the Valencian community (Spain).BMC Fam Pract. 2010 May 6;11:33. doi: 10.1186/1471-2296-11-33. BMC Fam Pract. 2010. PMID: 20459608 Free PMC article.
-
The epidemiology of Varicella Zoster Virus infection in Italy.BMC Public Health. 2008 Oct 27;8:372. doi: 10.1186/1471-2458-8-372. BMC Public Health. 2008. PMID: 18954432 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
